Companies: 10,795·Total market cap: $144.5T
CureVac N.V.

CureVac N.V.

CVACNASDAQHealthcare
$4.66
+$0.00(+0.00%)
Market Cap$1.0B
P/E Ratio
52W High$5.72
52W Low$2.475
Overview

CureVac N.V.(CVAC)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CVAC · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$0.54B$0.05B$0.07B$0.10B$0.05B
Cost of Revenue$0.11B$0.12B$0.18B$0.24B$0.01B
Gross Profit$0.43B($0.07B)($0.12B)($0.14B)$0.03B
Gross Margin %(computed)80.23%-131.34%-172.91%-131.28%71.02%
Operating Expenses
R&D Expenses$0.15B$0.12B$0.06B$0.82B$0.11B
G&A Expenses$0.07B$0.08B$0.09B$0.09B$0.05B
Total Operating Expenses$0.25B$0.20B$0.13B$0.28B$0.16B
Operating Income$0.18B($0.27B)($0.25B)($0.41B)($0.12B)
Operating Margin %(computed)33.20%-510.08%-370.00%-400.29%-253.58%
Interest Income$0.01B$0.02B$0.00B$0.01B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.01B$0.02B
Income Before Tax$0.19B($0.26B)($0.25B)($0.41B)($0.13B)
Income Tax Expense$0.03B$0.00B($0.00B)($0.00B)($0.00B)
Net Income$0.16B($0.26B)($0.25B)($0.41B)($0.13B)
Net Margin %(computed)30.30%-483.96%-369.37%-399.76%-263.96%
Per Share & EBITDA
EPS (Basic)$0.72$-1.18$-1.32$-2.21$-0.98
Wtd Avg Shares0.22B0.22B0.19B0.19B0.13B
EBITDA$0.21B($0.23B)($0.21B)($0.39B)($0.12B)
EBITDA Margin %(computed)39.18%-435.45%-310.57%-375.27%-251.73%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · EUR · B

深入了解CureVac N.V.

关于CureVac N.V.(CVAC)损益表

CureVac N.V.(CVAC)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,CVAC实现营收$0.54B,毛利润$0.43B(毛利率80.23%),净利润$0.16B(净利率30.30%)。

常见问题

CVAC · 4 问

CureVac N.V.(CVAC)2024财年营收为$0.54B,同比up895.5%。

CVAC revenueCVAC salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08